PTC Therapeutics logo
PTC Therapeutics PTCT
$ 40.92 1.3%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

PTC Therapeutics Balance Sheet 2011-2024 | PTCT

Annual Balance Sheet PTC Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-297 M 301 M 91.9 M 100 M 25.8 M -16.5 M 113 M 213 M 317 M -49.7 M -15.4 M 2.16 M -16.7 M

Long Term Debt

284 M 572 M 282 M 309 M 294 M 141 M 145 M 98.2 M 94.6 M - - 439 K 4.55 M

Long Term Debt Current

13 M 9.37 M 7.27 M 7.46 M 5.15 M 11.7 M - - - - 48.6 K - -

Total Non Current Liabilities

- - - - 794 M 602 M 153 M 100 M 96.7 M 2.28 M 2.23 M 4.11 M 240 M

Total Current Liabilities

603 M 406 M 509 M 277 M 236 M 167 M 82 M 49.6 M 45.4 M 32.5 M 13.1 M - -

Total Liabilities

2.71 B 2.05 B 1.94 B 1.73 B 1.03 B 768 M 235 M 150 M 142 M 34.8 M 15.4 M 32.3 M 283 M

Deferred Revenue

801 K 1.35 M - 4.15 M 8.24 M 3.72 M 3.94 M - 139 K 3.35 M 877 K 16.7 M 23 M

Retained Earnings

-3.28 B -2.66 B -2.1 B -1.63 B -1.19 B -939 M -814 M -735 M -593 M -423 M -329 M -277 M -251 M

Total Assets

1.9 B 1.71 B 1.94 B 2.21 B 1.62 B 1.12 B 392 M 269 M 368 M 333 M 152 M 13.1 M 44.1 M

Cash and Cash Equivalents

594 M 280 M 197 M 216 M 288 M 169 M 112 M 58.3 M 58 M 49.7 M 15.4 M 2.73 M 28.4 M

Book Value

-819 M -347 M 1.44 M 482 M 594 M 351 M 156 M 120 M 226 M 298 M 137 M -19.2 M -239 M

Total Shareholders Equity

-819 M -347 M 1.44 M 482 M 594 M 351 M 156 M 120 M 226 M 298 M 137 M -99.6 M -239 M

All numbers in USD currency

Quarterly Balance Sheet PTC Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

285 M 285 M 284 M 573 M 573 M 572 M 572 M 283 M - 282 M 282 M 282 M 430 M 430 M 309 M 309 M 309 M 309 M 294 M 294 M 294 M 294 M 141 M 141 M 141 M 141 M 145 M 145 M 145 M 145 M 98.2 M 98.2 M 98.2 M 98.2 M 91.8 M 91.8 M 91.8 M 91.8 M - - - - - - - - 439 K 439 K 439 K - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

2.9 B 2.68 B 2.71 B 1.93 B 1.92 B 2.07 B 2.05 B 1.8 B - 1.89 B 1.94 B 1.9 B 1.86 B 1.82 B 1.73 B 1.73 B 1.73 B 1.73 B 1.03 B 1.03 B 1.03 B 1.03 B 768 M 768 M 768 M 768 M 235 M 235 M 235 M 235 M 150 M 150 M 150 M 150 M 139 M 139 M 139 M 139 M 34.8 M 34.8 M 34.8 M 34.8 M 15.4 M 15.4 M 15.4 M 15.4 M 31.9 M 31.9 M 31.9 M - - - - -

Deferred Revenue

- - 801 K 1.22 M - 214 K 1.35 M - - - - - - 1.89 M 4.15 M 4.15 M 4.15 M 4.15 M 8.24 M 8.24 M 8.24 M 8.24 M 3.72 M 3.72 M 3.72 M - 3.94 M 6.12 M 2.6 M - - - - 396 K 139 K 139 K 139 K 139 K 3.35 M 3.35 M 3.35 M 3.35 M 878 K 878 K 878 K 878 K 16.7 M 16.7 M 16.7 M - - - - -

Retained Earnings

-3.47 B -3.38 B -3.28 B -3.13 B -2.99 B -2.8 B -2.66 B -2.49 B - -2.22 B -2.1 B -1.95 B -1.82 B -1.7 B -1.63 B -1.63 B -1.63 B -1.63 B -1.19 B -1.19 B -1.19 B -1.19 B -939 M -939 M -939 M -939 M -814 M -814 M -814 M -814 M -735 M -735 M -735 M -735 M -593 M -593 M -593 M -593 M -423 M -423 M -423 M -423 M -329 M -329 M -329 M -329 M -277 M -277 M -277 M - - - - -

Total Assets

1.92 B 1.79 B 1.9 B 1.26 B 1.34 B 1.61 B 1.71 B 1.58 B - 1.8 B 1.94 B 2.01 B 2.06 B 2.11 B 2.21 B 2.21 B 2.21 B 2.21 B 1.62 B 1.62 B 1.62 B 1.62 B 1.12 B 1.12 B 1.12 B 1.12 B 392 M 392 M 392 M 392 M 269 M 269 M 269 M 269 M 365 M 365 M 365 M 365 M 333 M 333 M 333 M 333 M 152 M 152 M 152 M 152 M 13.1 M 13.1 M 13.1 M - - - - -

Cash and Cash Equivalents

655 M 548 M 594 M 165 M 224 M 234 M 280 M 121 M 174 M 152 M 190 M 197 M 177 M 147 M 209 M 209 M 209 M 209 M 288 M 288 M 288 M 288 M 169 M 169 M 169 M 169 M 112 M 112 M 112 M 112 M 58.3 M 58.3 M 58.3 M 58.3 M 58 M 58 M 58 M 58 M 49.7 M 49.7 M 49.7 M 49.7 M 15.4 M 15.4 M 15.4 M 15.4 M 2.73 M 2.73 M 2.73 M - 28.4 M - - -

Book Value

-980 M -894 M -819 M -671 M -579 M -458 M -347 M -227 M - -90.6 M 1.44 M 105 M 197 M 293 M 482 M 482 M 482 M 482 M 594 M 594 M 594 M 594 M 351 M 351 M 351 M 351 M 156 M 156 M 156 M 156 M 120 M 120 M 120 M 120 M 226 M 226 M 226 M 226 M 298 M 298 M 298 M 298 M 137 M 137 M 137 M 137 M -18.8 M -18.8 M -18.8 M - - - - -

Total Shareholders Equity

-980 M -894 M -819 M -671 M -579 M -458 M -347 M -227 M -182 M -90.6 M 1.44 M 105 M 197 M 293 M 482 M 482 M 482 M 482 M 594 M 594 M 594 M 594 M 351 M 351 M 351 M 351 M 156 M 156 M 156 M 156 M 120 M 120 M 120 M 120 M 226 M 226 M 226 M 226 M 298 M 298 M 298 M 298 M 137 M 137 M 137 M 137 M -99.6 M -99.6 M -99.6 M - -239 M - - -

All numbers in USD currency